The Federal Government of Nigeria says the travel ban on Covishield COVID-19 vaccine which is the same as AstraZeneca vaccine that is produced in India is temporary.

This was made known by the Executive Director of the National Primary Health Care Development Agency (NPHCDA), Dr Faisal Shuaib during the joint weekly update on COVID-19 vaccine with World Health Organisation alongside UNICEF.

He explained that there are different validation processes that are used for different vaccines, adding that the European Union(EU) is not banning permanently or failing to recognise AstraZeneca from India.

According to him: “It is just that the Indian authorities have to also go through that process to get approved. It is not anything to be worried about”.

“The World Health Organization (WHO) actually came out very clearly to clear the air that it doesn’t mean that there is any inferiority in terms of the quality of the vaccination”.

“I am sure that in the next few days, you will read in the reports that indicate that the EU will accept vaccine certificates from those countries that have used the covishield or Oxford/AstraZeneca vaccine from India.”

Meanwhile, WHO has slammed the European Union (EU) on their position that travel certificates for Covishield that is produced in India will not be recognised by it for travel.

WHO's representative in India Kazadi Molumbo, stressed that due to the unequal spread in the availability of vaccines, especially between the rich and low-income countries, the presentation of proof of COVID-19 vaccination as a prerequisite for travel is untenable.

He further noted that all the vaccines that have been approved for emergency use listings are effective in providing protection against COVID-19 as the global health body stated that no country or region should be sanctioned or face travel restriction on the basis of COVID-19 vaccination.

“WHO has updated its recommendation as of July 2nd 2021. We do not recommend making proof of COVID-19 vaccination a necessary provision to enter any country.”

“This is particularly because of the widening and unequal spread in vaccine availability between the wealthy and lower-income countries.”

“Under the provisions of the International Health Regulations, vaccines will have to be approved by the WHO and be universally available before it can be considered as a prerequisite for travel.

“No region or country should face sanctions or restrictions because they are unable to get vaccines.”